We have all the 313 human non-sensory GPCRs in native sequences and provide functional assay for them in a single format, regardless of the subtypes of Gα proteins coupled. Click below for details.

Family
Panel
Filters Sort results
Reset Apply
Receptor
Family
Species
Assays
Human
Available
Assay modes:
Panels:
Reference agonist:
CCL1
EC50:
6.8 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
CCL25
EC50:
15 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
CCL27
EC50:
27 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
CXCL6
EC50:
20 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
CXCL6
EC50:
27 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
CXCL11
EC50:
29 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
cXCL12a
EC50:
5.4 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
CXCL13
EC50:
36 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
CXCL16
EC50:
3.9 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
XCL1
EC50:
43 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
CX3CL1
EC50:
1.8 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
CCK-8
EC50:
17 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
CCK-8
EC50:
490 pM
Human
Available
Assay modes:
Panels:
Reference agonist:
C3a
EC50:
3.7 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
EC50:
Human
Available
Assay modes:
Panels:
Reference agonist:
CRH
EC50:
22 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
urocortin
EC50:
23 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
dopamine
EC50:
260 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
dopamine
EC50:
260 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
dopamine
EC50:
220 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
dopamine
EC50:
260 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
dopamine
EC50:
250 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
ET-1
EC50:
5.5 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
ET-1
EC50:
5.0 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
7α,25-dihydroxycholesterol
EC50:
2.0 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
fMLP
EC50:
3.5 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
WKYMVM
EC50:
940 pM
Human
Available
Assay modes:
Panels:
FPR3
Reference agonist:
humanin
EC50:
5.9 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
TAK-875
EC50:
26 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
propionate Na
EC50:
880 µM
Human
Available
Assay modes:
Panels:
Reference agonist:
acetic acid
EC50:
100 µM
Human
Available
Assay modes:
Panels:
Reference agonist:
ZQ-16
EC50:
2.2 µM
Human
Available
Assay modes:
Panels:
Reference agonist:
GPR120 cpdA
EC50:
1.9 µM
Human
Available
Assay modes:
Panels:
Reference agonist:
baclofen
EC50:
9.4 µM
Human
Available
Assay modes:
Panels:
Reference agonist:
baclofen
EC50:
9.4 µM
Human
Available
Assay modes:
Panels:
Reference agonist:
galanin
EC50:
1.9 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
galanin
EC50:
1.3 nM
Human
Reference agonist:
EC50:
Human
Available
Assay modes:
Panels:
Reference agonist:
ghrelin
EC50:
4.0 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
GHRH
EC50:
2.0 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
GIP
EC50:
3.4 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
GLP1-(7-36)amide
EC50:
7.6 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
GLP2
EC50:
7.4 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
glucagon
EC50:
6.3 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
secretin
EC50:
7.6 nM
Human
Available
Assay modes:
Panels:
Reference agonist:
FSH
EC50:
8.6 ng/ml
Human
Available
Assay modes:
Panels:
Reference agonist:
rLHα/β
EC50:
26 ng/ml
Human
Available
Assay modes:
Panels:
Reference agonist:
TSH
EC50:
18 ng/ml
Human
Available
Assay modes:
Panels:
Reference agonist:
LH-RH
EC50:
93 pM
Human
Available
Assay modes:
Panels:
Reference agonist:
histamine
EC50:
17 nM
1 2 3 7

Contact Us

Send us a message via the form below or write to us at [email protected].

Ordering Process

Service flow chart

Request a quotation

We hear about the study outline and propose experiments. A non-disclosure agreement is optional.

STEP
1

Place an order

You also ship your compounds to our lab and pay the fee via bank transfer.

STEP
2

Wait for a while

The turnaround time may be as short as two weeks but depends on the study scale and design and the backlog of orders.

STEP
3

Receive the report

We provide the study report via email.

STEP
4

Inquiry & RFQ Form